FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3092865629> ?p ?o ?g. }

• W3092865629 endingPage "7644" @default.
• W3092865629 startingPage "7638" @default.
• W3092865629 abstract "Thailand is one of the countries in the Asia-pacific region that has been most affected by the Enterovirus-A71 (EV-A71) epidemic. An individual who is susceptible to EV-A71 may also be infected asymptomatically, thus, a serological assay is a useful tool to estimate the cumulative incidence of infection in the community and to provide guidance for vaccination scheduling. There have been several candidate EV-A71 vaccines, of which three have been approved and licensed in China. The population target for EV-A71 vaccine is children younger than three years of age. In Thailand, there are limited data available on the seroprevalence of EV-A71 neutralizing (NT) antibodies and the timing of seroconversion in children. This study aims to investigate the seroprevalence and seroconversion rate of EV-A71 NT antibody in a cohort of Thai children. Sera were collected at the King Chulalongkorn Memorial Hospital in Bangkok, Thailand from 100 children between 2015 and 2020. Maternal sera were collected on the day of delivery. Serum samples from children were collected at birth (month 0) and at 2, 7, 18, 24, 36, and 48 months of age to test for EV-A71 NT antibody titers using an enzyme-linked immunosorbent assay (ELISA)-based microneutralization test. The seroprotection rate (NT antibody ≥1:16) in children at months 0, 2, 7, 18, 24, 36, and 48 was 81.0%, 60.0%, 9.0%, 10.0%, 13.0%, 17.0%, and 37.1%, respectively. The seroprotection rate was lowest at month 7 due to waning of the maternal antibody and the immunity of children increased with increasing age. At 48 months of age, less than 40% of children were seroprotected. Children at the age of 6 months should be considered a primary target for vaccination." @default.
• W3092865629 created "2020-10-22" @default.
• W3092865629 creator A5024970229 @default.
• W3092865629 creator A5051156541 @default.
• W3092865629 creator A5067511913 @default.
• W3092865629 creator A5072307927 @default.
• W3092865629 creator A5082135516 @default.
• W3092865629 creator A5084305363 @default.
• W3092865629 creator A5085514301 @default.
• W3092865629 date "2020-11-01" @default.
• W3092865629 modified "2023-09-27" @default.
• W3092865629 title "Neutralizing antibody against Enterovirus-A71 in Thai children: A longitudinal study from birth to age 4 years" @default.
• W3092865629 cites W1968392370 @default.
• W3092865629 cites W1978453912 @default.
• W3092865629 cites W1989312232 @default.
• W3092865629 cites W1991256205 @default.
• W3092865629 cites W1995961101 @default.
• W3092865629 cites W1999404204 @default.
• W3092865629 cites W2013339538 @default.
• W3092865629 cites W2013518376 @default.
• W3092865629 cites W2020313443 @default.
• W3092865629 cites W2026318193 @default.
• W3092865629 cites W2052455354 @default.
• W3092865629 cites W2060089985 @default.
• W3092865629 cites W2061318078 @default.
• W3092865629 cites W2088456834 @default.
• W3092865629 cites W2128112837 @default.
• W3092865629 cites W2130206600 @default.
• W3092865629 cites W2153545807 @default.
• W3092865629 cites W2153819224 @default.
• W3092865629 cites W2163413888 @default.
• W3092865629 cites W2165200955 @default.
• W3092865629 cites W2172650261 @default.
• W3092865629 cites W2259136374 @default.
• W3092865629 cites W2315624236 @default.
• W3092865629 cites W2334359746 @default.
• W3092865629 cites W2523685835 @default.
• W3092865629 cites W2560747148 @default.
• W3092865629 cites W2791297820 @default.
• W3092865629 cites W2806632312 @default.
• W3092865629 cites W2897221522 @default.
• W3092865629 cites W2900789838 @default.
• W3092865629 cites W2922081627 @default.
• W3092865629 cites W2923974181 @default.
• W3092865629 cites W2952634094 @default.
• W3092865629 cites W2980480541 @default.
• W3092865629 cites W2980883207 @default.
• W3092865629 cites W3010523775 @default.
• W3092865629 cites W3018020531 @default.
• W3092865629 cites W4250869063 @default.
• W3092865629 doi "https://doi.org/10.1016/j.vaccine.2020.10.002" @default.
• W3092865629 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33067033" @default.
• W3092865629 hasPublicationYear "2020" @default.
• W3092865629 type Work @default.
• W3092865629 sameAs 3092865629 @default.
• W3092865629 citedByCount "2" @default.
• W3092865629 countsByYear W30928656292023 @default.
• W3092865629 crossrefType "journal-article" @default.
• W3092865629 hasAuthorship W3092865629A5024970229 @default.
• W3092865629 hasAuthorship W3092865629A5051156541 @default.
• W3092865629 hasAuthorship W3092865629A5067511913 @default.
• W3092865629 hasAuthorship W3092865629A5072307927 @default.
• W3092865629 hasAuthorship W3092865629A5082135516 @default.
• W3092865629 hasAuthorship W3092865629A5084305363 @default.
• W3092865629 hasAuthorship W3092865629A5085514301 @default.
• W3092865629 hasConcept C120665830 @default.
• W3092865629 hasConcept C121332964 @default.
• W3092865629 hasConcept C126322002 @default.
• W3092865629 hasConcept C159047783 @default.
• W3092865629 hasConcept C159654299 @default.
• W3092865629 hasConcept C187212893 @default.
• W3092865629 hasConcept C203014093 @default.
• W3092865629 hasConcept C22070199 @default.
• W3092865629 hasConcept C2777451964 @default.
• W3092865629 hasConcept C2778494684 @default.
• W3092865629 hasConcept C2779261636 @default.
• W3092865629 hasConcept C2908647359 @default.
• W3092865629 hasConcept C45189115 @default.
• W3092865629 hasConcept C61511704 @default.
• W3092865629 hasConcept C71924100 @default.
• W3092865629 hasConcept C72563966 @default.
• W3092865629 hasConcept C99454951 @default.
• W3092865629 hasConceptScore W3092865629C120665830 @default.
• W3092865629 hasConceptScore W3092865629C121332964 @default.
• W3092865629 hasConceptScore W3092865629C126322002 @default.
• W3092865629 hasConceptScore W3092865629C159047783 @default.
• W3092865629 hasConceptScore W3092865629C159654299 @default.
• W3092865629 hasConceptScore W3092865629C187212893 @default.
• W3092865629 hasConceptScore W3092865629C203014093 @default.
• W3092865629 hasConceptScore W3092865629C22070199 @default.
• W3092865629 hasConceptScore W3092865629C2777451964 @default.
• W3092865629 hasConceptScore W3092865629C2778494684 @default.
• W3092865629 hasConceptScore W3092865629C2779261636 @default.
• W3092865629 hasConceptScore W3092865629C2908647359 @default.
• W3092865629 hasConceptScore W3092865629C45189115 @default.
• W3092865629 hasConceptScore W3092865629C61511704 @default.
• W3092865629 hasConceptScore W3092865629C71924100 @default.
• W3092865629 hasConceptScore W3092865629C72563966 @default.

• next